Vivo Capital, LLC Q3 2019 Filing
Filed November 13, 2019
Portfolio Value
$878.8B
Holdings
5
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (5 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —Ascendis Pharma A/S | 2,060,135 | $198.4B | 22.58% | |
| 2 | —Arrowhead Pharmaceuticals Inc | 2,181,820 | $61.5B | 7.00% | |
| 3 | —Crinetics Pharmaceuticals Inc | 3,375,169 | $50.8B | 5.78% | |
| 4 | —Tricida, Inc. | 1,396,405 | $43.1B | 4.91% | |
| 5 | —Zymeworks Inc | 1,643,422 | $40.8B | 4.64% | |
| 6 | —Sinovac Biotech Ltd. | 5,900,000 | $38.2B | 4.34% | |
| 7 | —Codexis, Inc | 2,614,458 | $35.9B | 4.08% | |
| 8 | —Kadmon Holdings Inc | 12,606,605 | $31.8B | 3.61% | |
| 9 | —Amyris, Inc | 6,492,823 | $30.9B | 3.52% | |
| 10 | —Aurinia Pharmaceuticals Inc. | 4,754,358 | $25.4B | 2.89% | |
| 11 | —Insmed Inc | 1,398,338 | $24.7B | 2.81% | |
| 12 | —Homology Medicines, Inc. | 1,164,883 | $21.1B | 2.40% | |
| 13 | —Iovance Biotherapeutics, Inc. | 1,038,600 | $18.9B | 2.15% | |
| 14 | —Eiger BioPharmaceuticals Inc | 1,791,257 | $18.4B | 2.09% | |
| 15 | —Mirati Therapeutics Inc. | 233,045 | $18.2B | 2.07% | |
| 16 | —Menlo Therapeutics Inc. | 4,011,236 | $18.0B | 2.04% | |
| 17 | —KalVista Pharmaceuticals Inc. | 1,476,796 | $17.1B | 1.95% | |
| 18 | —Orchard Therapeutics plc | 1,312,084 | $15.6B | 1.77% | |
| 19 | —Xenon Pharmaceuticals Inc | 1,405,476 | $12.7B | 1.44% | |
| 20 | —Cymabay Therapeutics Inc | 2,154,934 | $11.0B | 1.26% | |
| 21 | —IGM Biosciences Inc | 593,756 | $10.5B | 1.20% | |
| 22 | —Avrobio Inc | 727,832 | $10.3B | 1.17% | |
| 23 | —MEI Pharma Inc | 5,644,477 | $9.5B | 1.08% | |
| 24 | —Apellis Pharmaceuticals, Inc. | 383,538 | $9.2B | 1.05% | |
| 25 | —Rocket Pharmaceuticals Inc | 786,712 | $9.2B | 1.04% | |
| 26 | —Chiasma Inc | 1,621,950 | $8.0B | 0.91% | |
| 27 | —Obseva SA | 937,147 | $7.8B | 0.89% | |
| 28 | —Zai Lab Limited | 222,107 | $7.2B | 0.82% | |
| 29 | —Protagonist Therapeutics Inc | 598,100 | $7.2B | 0.82% | |
| 30 | —Kiniksa Pharmaceuticals | 843,478 | $7.2B | 0.82% | |
| 31 | —Verona Pharma PLC | 1,492,951 | $6.8B | 0.78% | |
| 32 | —Soleno Therapeutics, Inc. | 4,268,959 | $6.4B | 0.73% | |
| 33 | —Nabriva Therapeutics AG | 2,754,486 | $5.5B | 0.63% | |
| 34 | —Karuna Therapeutics Inc | 325,000 | $5.3B | 0.60% | |
| 35 | —Galmed Pharmaceuticals Ltd | 955,670 | $4.6B | 0.52% | |
| 36 | —Dermira Inc | 700,000 | $4.5B | 0.51% | |
| 37 | —Matinas Biopharma Hldgs Inc | 6,818,181 | $4.3B | 0.49% | |
| 38 | —Zogenix Inc | 105,000 | $4.2B | 0.48% | |
| 39 | —Kala Pharmaceuticals, Inc. | 1,043,020 | $4.0B | 0.45% | |
| 40 | —Bellus Health Inc | 462,787 | $3.0B | 0.34% | |
| 41 | —Precision Biosciences Inc | 280,511 | $2.4B | 0.27% | |
| 42 | —DBV Technologies S.A. | 269,995 | $2.3B | 0.26% | |
| 43 | —Genocea Biosciences Inc | 626,401 | $1.8B | 0.21% | |
| 44 | —Agile Therapeutics, Inc. | 1,513,975 | $1.8B | 0.20% | |
| 45 | —Aclaris Therapeutics, Inc. | 1,647,214 | $1.8B | 0.20% | |
| 46 | —Selecta Biosciences Inc | 546,054 | $956.0M | 0.11% | |
| 47 | —Sierra Oncology, Inc | 2,438,270 | $952.0M | 0.11% | |
| 48 | —BioPharmX Corporation | 182,681 | $61.0M | 0.01% | |
| 49 | —Soleno Therapeutics, Inc. - Warrant | 188,772 | $9.0M | 0.00% |